Substance Use Disorder (SUD)
59
28
31
9
Key Insights
Highlights
Success Rate
90% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.7%
1 terminated out of 59 trials
90.0%
+3.5% vs benchmark
3%
2 trials in Phase 3/4
22%
2 of 9 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 9 completed trials
Clinical Trials (59)
WORTH Paths Intervention
Combining Social Network Strategies and Routine Substance Use Screening
Fighting Addictions, Improving Lives: COmprehensive Drug Rehabilitation With Music
Contextualization and Digitalization of WHO's Mental Health Action Gap Intervention Guide Substance Use Disorders Module
HABITS Study (Helping Addiction by Individualized Therapeutic Stimulation): Pilot Trial of Deep Brain Stimulation Guided By Stereoelectroencephalography for Treatment-Refractory Substance Use Disorders
Adolescent Stress and Substance Intervention Subsequent to Trauma
Adapted RPM-08 for Substance Use Disorder in Pakistan
Pathways to Perinatal Mental Health Equity
Implementation of TBI-RECOVER in Substance Use Treatment
Justice Community Overdose Innovation Network II TCU Hub
Evaluation of the ADD'Pro Vocational Reintegration Program (ADD-PRO-EVAL)
Identifying Substance Use Consequences
The Trans-Led Care Study
Incentives and Long-Acting Injectable Adherence After Involuntary Hospitalization
Metabolome and Gut Microbiome Changes During Smoking Cessation in Long-term Drug Therapy in a Therapeutic Community
Unified Junction of Care, Integrated Treatments and Team Coordination for ADHD in Prison Settings With Substance Use Disorder
Mindfulness-Based Psychoeducation With Substance Use and Anxiety Disorders
Long-acting Cabotegravir Injectable Pre-exposure Prophylaxis for People Who Inject Drugs
Calls and Coordination for Transitions of Care at Re-entry
Correctional Service of Canada Pilot Trial of Digital Substance Use Disorder Interventions (PROCESS)